Acute liver failure-induced hepatic encephalopathy is associated with changes in microRNA expression profiles in cerebral cortex of the rat

被引:0
|
作者
Raghu Vemuganti
Vinícius R. Silva
Suresh L. Mehta
Alan S. Hazell
机构
[1] University of Wisconsin,Department of Neurological Surgery
[2] University of Montreal,Department of Medicine
[3] Universidade Estadual de Campinas (UNICAMP),Departamento de Neurologia
[4] CRCHUM - Tour Viger R09-432,NeuroRescue Laboratory
来源
Metabolic Brain Disease | 2014年 / 29卷
关键词
Liver disease; miRNA; Non-coding RNA; Hepatic encephalopathy; Neuroprotection, Molecular signaling;
D O I
暂无
中图分类号
学科分类号
摘要
The mechanisms that promote brain dysfunction after acute liver failure (ALF) are not clearly understood. The small noncoding RNAs known as microRNAs (miRNAs) significantly control mRNA translation and thus normal and pathological functions in the mammalian body. To understand their significance in ALF, we currently profiled the expression of miRNAs in the cerebral cortex of mice sacrificed at coma stage following treatment with azoxymethane. Of the 470 miRNAs profiled using microarrays, 37 were significantly altered (20 up-and 17 down-regulated) in their expression in the ALF group compared to sham group. In silico analysis showed that the ALF-responsive miRNAs target on average 231 mRNAs/miRNA (range: 3 to 840 targets). Pathways analysis showed that many miRNAs altered after ALF target multiple mRNAs that are part of various biological and molecular pathways. Glutamatergic synapse, Wnt signaling, MAP-kinase signaling, axon guidance, PI3-kinase-AKT signaling, T-cell receptor signaling and ubiquitin-mediated proteolysis are the top pathways targeted by the ALF-sensitive miRNAs. At least 28 ALF-responsive miRNAs target each of the above pathways. We hypothesize that alterations in miRNAs and their down-stream mRNAs of signaling pathways might play a role in the induction and progression of neurological dysfunction observed during ALF.
引用
收藏
页码:891 / 899
页数:8
相关论文
共 50 条
  • [31] Let7f Expression Is Upregulated in the Frontal Cortex During Acute Liver Failure and Contributes to Hepatic Encephalopathy via Downregulation of IGF1 Expression
    Williams, Elaina
    Grant, Stephanie
    Petrescu, Anca
    Blaney, Hanna
    Davis, Sam
    Frampton, Gabriel
    McMillin, Matthew
    DeMorrow, Sharon
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S2 - S3
  • [32] Drug-induced-acute liver failure: A critical appraisal of the thioacetamide model for the study of hepatic encephalopathy
    Sepehrinezhad, Ali
    Shahbazi, Ali
    Negah, Sajad Sahab
    Joghataei, Mohammad Taghi
    Larsen, Fin Stolze
    TOXICOLOGY REPORTS, 2021, 8 : 962 - 970
  • [33] Decreased Expression and Uncoupling of Endothelial Nitric Oxide Synthase in the Cerebral Cortex of Rats with Thioacetamide-Induced Acute Liver Failure
    Milewski, Krzysztof
    Czarnecka, Anna Maria
    Albrecht, Jan
    Zielinska, Magdalena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
  • [34] Cerebral oedema is rare in acute-on-chronic liver failure patients presenting with high-grade hepatic encephalopathy
    Joshi, Deepak
    O'Grady, John
    Patel, Amit
    Shawcross, Debbie
    Connor, Steven
    Deasy, Neil
    Willars, Chris
    Bernal, William
    Wendon, Julia
    Auzinger, Georg
    LIVER INTERNATIONAL, 2014, 34 (03) : 362 - 366
  • [35] HEPATIC-ENCEPHALOPATHY IN RATS WITH THIOACETAMIDE-INDUCED ACUTE LIVER-FAILURE IS NOT MEDIATED BY ENDOGENOUS BENZODIAZEPINES
    PUSPOK, A
    HERNETH, A
    STEINDL, P
    FERENCI, P
    GASTROENTEROLOGY, 1993, 105 (03) : 851 - 857
  • [36] Heart failure-induced myosin heavy chain changes in rat diaphragm muscle are not related to gene expression of myogenic regulatory factors
    Lima, A. R. R.
    Martinez, P. F.
    Damatto, R. L.
    Zornoff, L. A. M.
    Cezar, M. D. M.
    Guizoni, D. M.
    Bonomo, C.
    Rosa, C. M.
    Okoshi, K.
    Okoshi, M. P.
    EUROPEAN HEART JOURNAL, 2010, 31 : 426 - 426
  • [37] The effect of the molecular adsorbent recycling system (MARS) on cerebral perfusion in patients with acute on chronic liver failure and hepatic encephalopathy.
    Schmidt, LE
    Svendsen, LB
    Sorensen, VR
    Mitzner, SR
    Hansen, BA
    Larsen, FS
    HEPATOLOGY, 2000, 32 (04) : 612A - 612A
  • [38] GALACTOSAMINE INDUCED FULMINANT HEPATIC-FAILURE IN THE RAT MAY BE AN UNSUITABLE MODEL FOR ACUTE HEPATIC-ENCEPHALOPATHY - A COMPARISON WITH THE RABBIT MODEL
    MULLEN, KD
    SCHAFER, DF
    MAYNARD, TF
    DEKNEGT, R
    JONES, DB
    ROESSLE, M
    JONES, EA
    GASTROENTEROLOGY, 1986, 90 (05) : 1750 - 1750
  • [39] Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure
    Kamat, Pradip
    Kunde, Sachin
    Vos, Miriam
    Vats, Atul
    Gupta, Nitika
    Heffron, Thomas
    Romero, Rene
    Fortenberry, James D.
    PEDIATRIC CRITICAL CARE MEDICINE, 2012, 13 (01) : E33 - E38
  • [40] INCREASED SEROTONINERGIC AND NORADRENERGIC ACTIVITY IN HEPATIC-ENCEPHALOPATHY IN RATS WITH THIOACETAMIDE-INDUCED ACUTE LIVER-FAILURE
    YURDAYDIN, C
    HORTNAGL, H
    STEINDL, P
    ZIMMERMANN, C
    PIFL, C
    SINGER, EA
    ROTH, E
    FERENCI, P
    HEPATOLOGY, 1990, 12 (04) : 695 - 700